Johnson & Johnson secured FDA approval for its Dual Energy THERMOCOOL SMARTTOUCH SF Platform.

The system allows electrophysiologists to toggle between radiofrequency and pulsed field energy using a single catheter. This integrated solution provides increased versatility for treating complex cardiac cases.

The platform connects directly with J&Jā€™s existing CARTO 3D mapping system. A phased commercial rollout in the U.S. begins this summer following a successful European launch.

The approval expands a MedTech portfolio that has already treated more than one million patients.